A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections
- PMID: 16107960
- PMCID: PMC1483060
- DOI: 10.1086/432732
A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections
Abstract
Human metapneumovirus (hMPV) is a recently described paramyxovirus associated with upper and lower respiratory-tract infection (URI and LRI, respectively). We conducted a prospective study of URI and LRI in adults with hematologic malignancies during a 4-year period. We retrospectively tested samples by reverse-transcription polymerase chain reaction for hMPV and analyzed clinical data. Twenty-two (9%) of 251 episodes of respiratory infection tested positive for hMPV. Sixteen (73%) of the illnesses occurred in hematopoietic stem-cell transplant recipients. Nine patients with hMPV developed LRI; 3 of these patients died. hMPV is a common cause of respiratory infections in adults with hematologic malignancies, with associated morbidity and mortality.
Conflict of interest statement
Potential conflicts of interest: none reported.
References
-
- Whimbey E, Champlin R, Couch R, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant patients. Clin Infect Dis. 1996;22:778–82. - PubMed
-
- Llungman P. Respiratory virus infections in bone marrow transplant patients: the European perspective. Am J Med. 1997;102:44–7. - PubMed
-
- Bowden RA. Respiratory virus infection after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med. 1997;102:27–30. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources